Triptorelin vs Leuprolide
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Trelstar, Triptodur
Triptorelin is a synthetic analog of gonadotropin-releasing hormone (GnRH) with a D-tryptophan swapped in at position 6, which makes it far more potent and longer-lasting than the natural hormone. As a long-acting depot it is FDA-approved to shut down testosterone in advanced prostate cancer (Trelstar) and to pause early puberty in children (Triptodur), and in Europe it is sold as Decapeptyl, including a short-acting 0.1 mg form used in IVF. In men's health circles it is known for something else: a single small dose used to 'restart' testosterone after steroid use. That idea rests on very little published evidence.
Also: Lupron, Lupron Depot
Leuprolide (brand name Lupron) is a synthetic GnRH agonist, a modified peptide far more potent than natural GnRH, and it is FDA-approved for advanced prostate cancer, endometriosis, uterine fibroids, and central precocious puberty. The clever part is counterintuitive: it works by overstimulating the GnRH system so hard that the pituitary shuts down sex hormone production. It is a real, long-established prescription drug (first US approval 1985), not a research peptide, and it carries meaningful side effects from the low-hormone state it creates.
Key Comparison Insights
- Both Triptorelin and Leuprolide are FDA approved medications.
- Both peptides belong to the Hormonal category, suggesting similar primary applications.
Detailed Comparison
| Attribute | Triptorelin | Leuprolide |
|---|---|---|
| Category | Hormonal | Hormonal |
| FDA Status | FDA Approved | FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | Triptorelin binds GnRH receptors on the pituitary. The first exposure causes a big release of LH and FSH (the 'flare'), which pushes the testes to make more testosterone for a few days. With continuous exposure, as from a depot injection, the receptors desensitize and LH and FSH collapse, driving testosterone down to castrate levels within about 2 to 4 weeks. That is the whole point of the prostate cancer use. The single-dose restart idea tries to use only the flare: one short-acting dose stimulates the pituitary without enough ongoing exposure to shut it down. The catch is that the formulation matters enormously. A depot dose of triptorelin is designed to suppress testosterone for 1 to 6 months, which is the opposite of what someone trying to recover wants. | Leuprolide is a superagonist at the pituitary GnRH receptor. When you first give it, it strongly stimulates the receptor and causes a transient surge in LH, FSH, and sex hormones, the so-called flare. With continuous exposure, the pituitary internalizes and downregulates its GnRH receptors and becomes desensitized, so within roughly two to four weeks LH and FSH plummet and gonadal testosterone or estrogen falls to near-castrate levels. In prostate cancer, removing testosterone starves androgen-dependent tumor cells; in endometriosis and fibroids, dropping estrogen shrinks hormone-driven tissue and eases pain. That early flare is clinically important because it can briefly worsen symptoms in prostate cancer or endometriosis, which is why doctors sometimes co-administer other drugs to blunt it. |
| Common Dosing | Depot per label (3.75-22.5 mg); 100 mcg single dose for restart (community-reported) Single dose for the stimulation test; every 4, 12 or 24 weeks for depots | Variable - depends on formulation Daily, monthly, or every 3-6 months |
| Administration | Intramuscular injection (depots); subcutaneous or intramuscular for the 100 mcg short-acting dose | Intramuscular or subcutaneous depot injection |
| Typical Duration | Ongoing for approved depot uses; single injection for the stimulation test | Months to years depending on indication |
| Best Time to Take | Morning for the single 100 mcg dose; depots on the scheduled date | Morning or as directed |
Possible Side Effects May vary by individual |
|
|
| Research Summary | For the approved uses, the evidence is solid. Trelstar labeling shows testosterone rising for the first few days, peaking on days 2 to 4, then falling to castrate levels (under 50 ng/dL) by weeks 3 to 4 in men with prostate cancer, with effects usually reversible after stopping. Triptodur is approved for central precocious puberty in children 2 and older. A 100 mcg triptorelin stimulation test is also an established diagnostic tool: a Chinese study of 229 males found LH peaked 45 to 60 minutes after the injection and that the peak level helped separate delayed puberty from hypogonadotropic hypogonadism. The HPTA restart use is much thinner. The best-known source is a 2010 Fertility and Sterility case report of one 34-year-old man with hypogonadism after internet-bought anabolic steroids: he got a single 100 mcg triptorelin test dose and his testosterone was back in the normal range within a month. That is one patient, no control group, and the dose was given as a diagnostic test, not as a treatment. A 2023 scoping review in Endocrine Connections found that gonadotropins usually recover on their own within 3 to 6 months after steroids stop, while testosterone recovery is often incomplete, and it did not identify triptorelin as a studied recovery treatment. Bottom line: plausible, cheap, and popular, but not proven to beat natural recovery or standard options. | Leuprolide has decades of clinical trial and real-world evidence behind it. It was first FDA-approved in 1985 as a daily injection, with the long-acting Lupron Depot following, and newer forms like Eligard, Fensolvi (6-month pediatric, 2020) and Camcevi (2021) came later, so unlike most peptides in this space its efficacy is not in question. GnRH agonists like leuprolide largely replaced surgical castration in prostate cancer management because they achieve the same hormonal suppression reversibly. In endometriosis and fibroids, trials show it reduces lesion size, pelvic pain, and bleeding, and it is a standard tool for central precocious puberty in children. The trade-off is the low-estrogen or low-testosterone state it induces, which brings hot flashes, bone density loss with longer use, and other menopausal or andropausal effects, so courses are often limited or paired with add-back hormone therapy. Labels also warn about high blood sugar and heart risk in men on long-term treatment, and psychiatric symptoms, seizures and pseudotumor cerebri in children. This is a mainstream oncology and gynecology drug; the honest framing is that it is highly effective for its approved uses and that its 'side effects' are the direct, expected consequence of shutting down sex hormones. |
Frequently Asked Questions: Triptorelin vs Leuprolide
What is the difference between Triptorelin and Leuprolide?
Triptorelin is a hormonal peptide that triptorelin is a synthetic analog of gonadotropin-releasing hormone (gnrh) with a d-tryptophan swapped in at position 6, which makes it far more potent and longer-lasting than the natural hormone. as a long-acting depot it is fda-approved to shut down testosterone in advanced prostate cancer (trelstar) and to pause early puberty in children (triptodur), and in europe it is sold as decapeptyl, including a short-acting 0.1 mg form used in ivf. in men's health circles it is known for something else: a single small dose used to 'restart' testosterone after steroid use. that idea rests on very little published evidence. Leuprolide is a hormonal peptide that leuprolide (brand name lupron) is a synthetic gnrh agonist, a modified peptide far more potent than natural gnrh, and it is fda-approved for advanced prostate cancer, endometriosis, uterine fibroids, and central precocious puberty. the clever part is counterintuitive: it works by overstimulating the gnrh system so hard that the pituitary shuts down sex hormone production. it is a real, long-established prescription drug (first us approval 1985), not a research peptide, and it carries meaningful side effects from the low-hormone state it creates. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Triptorelin or Leuprolide?
Neither is universally "better" - the choice depends on your specific goals. Triptorelin is typically used for hormonal purposes, while Leuprolide is used for hormonal. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Triptorelin and Leuprolide be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Triptorelin and Leuprolide together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.